Chitosan-palmitic acid based polymeric micelles as promising carrier for circumventing pharmacokinetic and drug delivery concerns of tamoxifen

N Thotakura, M Dadarwal, R Kumar, B Singh… - International journal of …, 2017 - Elsevier
Being a BCS class II drug and a good substrate for microsomal enzymes, tamoxifen (TAM)
offers a scope for research owing to poor aqueous solubility and compromised …

Chitosan-stearic acid based polymeric micelles for the effective delivery of tamoxifen: cytotoxic and pharmacokinetic evaluation

N Thotakura, M Dadarwal, P Kumar, G Sharma… - Aaps Pharmscitech, 2017 - Springer
Chitosan is a widely employed polysaccharide with positive zeta-potential and better
tissue/cell adhesion. Its hydrophilicity, high viscosity, and insolubility at physiological pH are …

Enhanced efficacy and a better pharmacokinetic profile of tamoxifen employing polymeric micelles

H Yadav, P Kumar, V Sharma, G Sharma, K Raza… - Rsc Advances, 2016 - pubs.rsc.org
The present work aims to develop tamoxifen-loaded polymeric micelles and explore their
potential in topical delivery of the drug to breast cancer cells. The PLGA–PEG copolymer …

Biocompatible Phospholipid-Based Mixed Micelles for Tamoxifen Delivery: Promising Evidences from In - Vitro Anticancer Activity and Dermatokinetic Studies

P Kumar, R Kumar, B Singh, R Malik, G Sharma… - Aaps pharmscitech, 2017 - Springer
Tamoxifen (TAM) is frequently prescribed for the management breast cancer, but is
associated with the challenges like compromised aqueous solubility and poor bioavailability …

Chitosan-modified PLGA polymeric nanocarriers with better delivery potential for tamoxifen

CK Thakur, N Thotakura, R Kumar, P Kumar… - International journal of …, 2016 - Elsevier
Breast cancer is believed as the second most common cause of cancer-related deaths in
women for which tamoxifen is frequently prescribed. Despite many promises, tamoxifen is …

Polymeric micelles based on amphiphilic oleic acid modified carboxymethyl chitosan for oral drug delivery of bcs class iv compound: Intestinal permeability and …

R Kumar, A Sirvi, S Kaur, SK Samal, S Roy… - European Journal of …, 2020 - Elsevier
Chemical modification of chitosan derivatives with hydrophobic fatty acids to enhance their
self-aggregation behavior is well established. Previously our group reported low molecular …

Formulation of chitosan based lipid polymer hybrid nanocarrier system for oral delivery of tamoxifen citrate: Toxicological and hemocompatibility evaluation

M Khan, M Akhtar, A Majeed, H Sadaquat… - Journal of Drug Delivery …, 2024 - Elsevier
The objective of the current work was to develop chitosan based lipid nanocarriers for the
oral controlled release of tamoxifen citrate (TC). The ionic gelation method was used to …

Development and evaluation of polymeric micelle containing tablet formulation for poorly water-soluble drug: Tamoxifen citrate

K Öztürk-Atar, M Kaplan, S Çalış - Drug Development and Industrial …, 2020 - Taylor & Francis
Poor aqueous solubility is one of the key reasons for slow dissolution rate and poor
intestinal absorption and finally that causes low therapeutic efficacy of many existing drugs …

Development of novel polymer-lipid hybrid nanoparticles of tamoxifen: in vitro and in vivo evaluation

M Varthya, H Pawar, C Singh, CP Dora… - … of Nanoscience and …, 2016 - ingentaconnect.com
This study was undertaken to develop and investigate the effect of tamoxifen polymer-lipid
hybrid nanoparticles (Tmx-PLN) on its oral bioavailability and efficacy in the 7, 12 …

Chitosan nanoparticles for tamoxifen delivery and cytotoxicity to MCF-7 and Vero cells

NR Ravikumara, B Madhusudhan - Pure and Applied Chemistry, 2011 - degruyter.com
In this study, tamoxifen citrate-loaded chitosan nanoparticles (tamoxcL-ChtNPs) and
tamoxifen citrate-free chitosan nanoparticles (tamoxcF-ChtNPs) were prepared by an ionic …